Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 187

1.
2.

Biological activity of S-nitrosothiols: the role of nitric oxide.

Mathews WR, Kerr SW.

J Pharmacol Exp Ther. 1993 Dec;267(3):1529-37.

PMID:
7903392
3.

Potential therapeutic uses for S-nitrosothiols.

Richardson G, Benjamin N.

Clin Sci (Lond). 2002 Jan;102(1):99-105. Review.

PMID:
11749666
4.
5.

Mechanism of nitric oxide release from S-nitrosothiols.

Singh RJ, Hogg N, Joseph J, Kalyanaraman B.

J Biol Chem. 1996 Aug 2;271(31):18596-603.

6.

S-nitrosothiols inhibit uterine smooth muscle cell proliferation independent of metabolism to NO and cGMP formation.

Cornwell TL, Ceaser EK, Li J, Marrs KL, Darley-Usmar VM, Patel RP.

Am J Physiol Cell Physiol. 2003 Jun;284(6):C1516-24. Epub 2003 Feb 12.

PMID:
12584112
7.

One-electron reduction of S-nitrosothiols in aqueous medium.

Manoj VM, Mohan H, Aravind UK, Aravindakumar CT.

Free Radic Biol Med. 2006 Oct 15;41(8):1240-6. Epub 2006 Jul 11.

PMID:
17015170
8.

Copper chelation-induced reduction of the biological activity of S-nitrosothiols.

Gordge MP, Meyer DJ, Hothersall J, Neild GH, Payne NN, Noronha-Dutra A.

Br J Pharmacol. 1995 Mar;114(5):1083-9.

9.

Rapid S-nitrosothiol metabolism by platelets and megakaryocytes.

Shah CM, Locke IC, Chowdrey HS, Gordge MP.

Biochem Soc Trans. 2003 Dec;31(Pt 6):1450-2.

PMID:
14641087
10.

Role of a copper (I)-dependent enzyme in the anti-platelet action of S-nitrosoglutathione.

Gordge MP, Hothersall JS, Neild GH, Dutra AA.

Br J Pharmacol. 1996 Oct;119(3):533-8.

11.

S-Transnitrosation reactions are involved in the metabolic fate and biological actions of nitric oxide.

Liu Z, Rudd MA, Freedman JE, Loscalzo J.

J Pharmacol Exp Ther. 1998 Feb;284(2):526-34.

12.

Study of the effect of thiols on the vasodilatory potency of S-nitrosothiols by using a modified aortic ring assay.

Giustarini D, Tsikas D, Rossi R.

Toxicol Appl Pharmacol. 2011 Oct 15;256(2):95-102. doi: 10.1016/j.taap.2011.07.011. Epub 2011 Jul 24.

PMID:
21827780
13.

Effect of pH and metal ions on the decomposition rate of S-nitrosocysteine.

Gu J, Lewis RS.

Ann Biomed Eng. 2007 Sep;35(9):1554-60. Epub 2007 May 18.

PMID:
17510805
14.

Topically applied S-nitrosothiol-containing hydrogels as experimental and pharmacological nitric oxide donors in human skin.

Seabra AB, Fitzpatrick A, Paul J, De Oliveira MG, Weller R.

Br J Dermatol. 2004 Nov;151(5):977-83.

PMID:
15541075
15.

GC-MS analysis of S-nitrosothiols after conversion to S-nitroso-N-acetyl cysteine ethyl ester and in-injector nitrosation of ethyl acetate.

Tsikas D, Dehnert S, Urban K, Surdacki A, Meyer HH.

J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Oct 15;877(28):3442-55. doi: 10.1016/j.jchromb.2009.06.032. Epub 2009 Jun 30.

PMID:
19595646
16.

Nitric oxide and S-nitrosothiols in human blood.

Giustarini D, Milzani A, Colombo R, Dalle-Donne I, Rossi R.

Clin Chim Acta. 2003 Apr;330(1-2):85-98. Review.

PMID:
12636927
17.

Understanding the controversy over the identity of EDRF.

Feelisch M, te Poel M, Zamora R, Deussen A, Moncada S.

Nature. 1994 Mar 3;368(6466):62-5.

PMID:
8107883
18.
19.

In vitro vasorelaxant and in vivo cardiovascular effects of S-nitrosothiols: comparison to and cross tolerance with standard nitrovasodilators.

Smith MP, Humphrey SJ, Kerr SW, Mathews WR.

Methods Find Exp Clin Pharmacol. 1994 Jun;16(5):323-35.

PMID:
7934311
20.

Is ceruloplasmin an important catalyst for S-nitrosothiol generation in hypercholesterolemia?

Moriel P, Pereira IR, Bertolami MC, Abdalla DS.

Free Radic Biol Med. 2001 Feb 1;30(3):318-26.

PMID:
11165878

Supplemental Content

Support Center